Mirae Asset Global Investments’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,743
Closed -$9.46K 1697
2025
Q2
$9.46K Buy
1,743
+235
+16% +$1.17K ﹤0.01% 1499
2025
Q1
$5.29K Buy
1,508
+6
+0.4% +$29 ﹤0.01% 1512
2024
Q4
$15.4K Buy
1,502
+16
+1% +$199 ﹤0.01% 1456
2024
Q3
$20.1K Buy
1,486
+263
+22% +$3.26K ﹤0.01% 1433
2024
Q2
$15.7K Buy
+1,223
New +$15.1K ﹤0.01% 1414

Other funds holding THRD

Mirae Asset Global Investments's THRD Position: Q3 2025 in Review

Mirae Asset Global Investments sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 1,743 shares — an estimated $9.46K sold.

Mirae Asset Global Investments first reported a position in THRD in Q2 2024 and held it in 5 quarters. The position peaked at $20.1K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Mirae Asset Global Investments reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,743 Third Harmonic Bio shares in Q3 2025, an estimated $9.46K.
  • Mirae Asset Global Investments first reported a position in Third Harmonic Bio in Q2 2024 and held it in 5 quarters.
  • Mirae Asset Global Investments's Third Harmonic Bio position peaked at $20.1K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.